EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, NeueHealth's enterprise value is $1,249 Mil.
NeueHealth's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-608 Mil. Therefore, NeueHealth's EV-to-EBITDA for today is -2.05.
The historical rank and industry rank for NeueHealth's EV-to-EBITDA or its related term are showing as below:
NEUE'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -55.87 Med: -2.4 Max: 2.18
Current: -2.05
During the past 6 years, the highest EV-to-EBITDA of NeueHealth was 2.18. The lowest was -55.87. And the median was -2.40.
NEUE's EV-to-EBITDA is ranked worse than 100% of 15
companies
in the Healthcare Plans industry
Industry Median: 8.25
vs NEUE: -2.05
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-05-05), NeueHealth's stock price is $6.25.
NeueHealth's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-151.060. Therefore, NeueHealth's PE Ratio for today is At Loss.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
NeueHealth EV-to-EBITDA Historical Data
The historical data trend for NeueHealth's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of NeueHealth's EV-to-EBITDA
For the Healthcare Plans subindustry, NeueHealth's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NeueHealth's EV-to-EBITDA Distribution in the Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, NeueHealth's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where NeueHealth's EV-to-EBITDA falls into.
NeueHealth EV-to-EBITDA Calculation
NeueHealth's EV-to-EBITDA for today is calculated as:
NeueHealth's current Enterprise Value is $1,249 Mil.
NeueHealth's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-608 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NeueHealth (NYSE:NEUE) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
NeueHealth's share price for today is $6.25.
NeueHealth's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-151.060.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of NeueHealth's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Bright Health Group Inc is a technology-enabled, value-driven healthcare company focused on delivering affordable healthcare to the fast-growing aging and underserved populations in Florida, Texas, and California. It consists of two reportable segments: Bright HealthCare includes delegated senior managed care business that partners with a tight group of aligned providers in California focused on serving aging and underserved populations with unmet clinical needs through a Fully-Aligned Care Model, and Consumer Care includes a value-driven care delivery business that manages risk in partnership with external payors, It aims to significantly reduce the friction and current lack of coordination between payors by delivering on its Fully-Aligned Care Model with multiple payors.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NEUE has been successfully added to your 